Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 75Neoplasm Metastasis 12Neoplasms 8Ovarian Neoplasms 6Endometrial Neoplasms 6Pancreatic Neoplasms 5Carcinoma, Renal Cell 5Sarcoma 4Neoplasms by Site 4Lymphoma, Non-Hodgkin 4Breast Diseases 4Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lymphoma 3Lung Neoplasms 3Liposarcoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Glioma 3Wilms Tumor 2Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2

Interventions

pembrolizumab 25Cisplatin 20Carboplatin 14Paclitaxel 11Radiotherapy 9Radiotherapy, Intensity-Modulated 8Docetaxel 8Cetuximab 8Nivolumab 6cemiplimab 5Radiation 5durvalumab 4atezolizumab 3Taxes 3Surveys and Questionnaires 3Fluorouracil 3Drug Therapy 3Cyclophosphamide 3Blood Specimen Collection 3toripalimab 2olaparib 2fludarabine 2avelumab 2alpha-2'-deoxythioguanosine 2aldesleukin 2Surgical Procedures, Operative 2Standard of Care 2Pemetrexed 2Magnetic Resonance Spectroscopy 2vistusertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × palbociclib × 1 year × Clear all
NCT02664935 2026-04-28

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

University of Birmingham

Phase 2 Completed
423 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡